COI-B
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for COI-B, covering 2019-08-07 to 2019-08-07. Get the full timeline:
Most recent: Clinical Trial Update: PERIOPERATIVE TREATMENT WITH COI-B (CAPECITABINE, OXALIPLATIN, IRINOTECAN AND BEVACIZUMAB) OF HIGH RISK OR BORDERLINE RESECTABLE COLORECTAL CANCER LIVER METASTASES [Phase 2]